- Home
- HBT vs TLRY Comparison
HBT vs TLRY Comparison
Compare HBT & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HBT | TLRY |
|---|---|---|
| Founded | 1920 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 688.9M |
| IPO Year | 2019 | 2018 |
Fundamental Metrics
Financial Performance| Metric | HBT | TLRY |
|---|---|---|
| Price | $28.63 | $5.51 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 4 |
| Target Price | $30.75 | ★ $72.33 |
| AVG Volume (30 Days) | 70.9K | ★ 3.5M |
| Earning Date | 04-27-2026 | 04-01-2026 |
| Dividend Yield | ★ 3.29% | N/A |
| EPS Growth | ★ 7.96 | N/A |
| EPS | ★ 0.34 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $35.73 | $8.79 |
| Revenue Next Year | $7.01 | $19.98 |
| P/E Ratio | $84.06 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $22.36 | $0.36 |
| 52 Week High | $29.88 | $15.70 |
Technical Indicators
Market Signals| Indicator | HBT | TLRY |
|---|---|---|
| Relative Strength Index (RSI) | 56.96 | 42.97 |
| Support Level | $27.15 | $5.09 |
| Resistance Level | $29.14 | $7.01 |
| Average True Range (ATR) | 0.59 | 0.21 |
| MACD | 0.10 | 0.06 |
| Stochastic Oscillator | 76.64 | 68.95 |
Price Performance
Historical ComparisonAbout HBT HBT Financial Inc.
HBT Financial Inc provides a comprehensive suite of business, commercial, wealth management, and retail banking products and services to individuals, businesses, and municipal entities throughout Central and Northeastern Illinois and Eastern Iowa. It operates through one reportable segment: community banking. It generates revenue from Card income, Wealth management fees, and Service charges on deposit accounts.
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.